Publicaciones científicas - Dr Adrián Hernández Martínez

Iris-claw intraocular lens implantation: Efficiency and safety according to technique. J Cataract Refract Surg 2018; 44:1186–1191
Early versus late switch: How long should we extend the anti-vascular endothelial growth factor therapy in unresponsive diabetic macular edema patients?. European Journal of Ophthalmology.2020 Sep;30(5):1091-1098.
Retropupillary iris-claw intraocular lens and pars plana vitrectomy in aphakia management: A national multicenter audit. Retina. 2021 Mar.
Iris-claw intraocular lens: Anterior chamber o retropupillary implantatio? A systematic review and meta-analysis. Medicina 2021, 57(8), 785.
Refractive and Visual Outcomes of a Monofocal Non-Constant Aberration Aspheric Intraocular Lens. Clinical ophthalmology. 2022; 16: 2521-253.
Predictive Factors and Management of Macular Edema after Retropupillary Iris-Claw Intraocular Lens Implantation in Aphakia: National Multicenter Audit-Report 2. J. Clin. Med. 2023, 12(2), 436

Retina, práctica clínica caso a caso. (Autor 4 capítulos) ISBN: 978-8496727-98-4
Monografía Secoir 2015: Óptica para el cirujano faco-refractivo. (Co-autor capítulo 30). ISBN: 978-84-9022-956-9

Efecto del colirio de bromfenaco 0.9 mg/ml en la percepción del dolor tras la inyección intravítrea de medicamentos. Investigador principal. Nº EudraCT: 2015-002155-10. Registro Español de Ensayos Clínicos (REEC): REec-2016-2380